id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0306-0004,FDA,FDA-2007-D-0306,"Q4B Evaluation and Recommendation of Pharmacopeial Texts for Use in the ICH Regions, Annex 3 - Guidance",Supporting & Related Material,GDL-Guidance,2009-01-12T05:00:00Z,2009,1,,,2010-04-07T16:41:58Z,,0,0,090000648081aa50
FDA-2007-D-0306-0003,FDA,FDA-2007-D-0306,"International Conference on Harmonisation:  Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions,",Notice,NAD-Notice of Availability of Data,2009-01-09T05:00:00Z,2009,1,2009-01-09T05:00:00Z,,2024-11-12T04:27:27Z,E9-00214,1,0,0900006480819594
FDA-2007-D-0306-0002,FDA,FDA-2007-D-0306,International Conference on Harmonisation; Draft Guidance on Q4B,Notice,NAD-Notice of Availability of Data,2007-12-18T05:00:00Z,2007,12,2007-12-14T05:00:00Z,2008-02-16T04:59:59Z,2009-01-12T16:01:41Z,,0,0,090000648042b66c
FDA-2007-D-0306-0001,FDA,FDA-2007-D-0306,"4QB Evaluation and Recommendation of Pharmacopeial Texts for Use in the ICH Regions, Annex 3 - Guidance - Draft Guidance",Supporting & Related Material,GDL-Guidance,2007-12-18T05:00:00Z,2007,12,,,2009-01-12T16:04:33Z,,0,0,090000648042b66d